Oral Sildenafil for Treatment of Severe Pulmonary Hypertension in an Infant
Authors:
- Kam-Lau CheungKCKam-Lau Cheung
- Kiu-Lok SiuKSKiu-Lok Siu
- Ting-Fan LeungTLTing-Fan Leung
- Man-Ching YamMYMan-Ching Yam
- Tai-Fai FokTFTai-Fai Fok
- Pak-Cheung NgPNPak-Cheung Ng
- 1 August 2005
- journal article
- case report
- Published by S. Karger AG in Neonatology
- Vol. 88 (2) , 109-112
Abstract
We report the use of oral sildenafil in a 5-month-old preterm infant with severe bronchopulmonary dysplasia and pulmonary arterial hypertension refractory to inhaled nitric oxide treatment, maximal ventilatory support and conventional vasodilator therapy. Sildenafil was prepared as a liquid suspension by the method of trituration and administered via an orogastric tube to the patient. Forty-eight hours after sildenafil treatment, echocardiography revealed that the tricuspid incompetence was substantially diminished and the contractility of both ventricles improved, indicating a marked reduction in pulmonary arterial pressure. Oral sildenafil treatment was continued for 6 months until complete resolution of pulmonary arterial hypertension, and oxygen supplement was weaned off. There was no adverse effect during the treatment period. Oral sildenafil may be useful in reducing pulmonary vascular resistance and can be considered for treatment of severe pulmonary arterial hypertension secondary to bronchopulmonary dysplasia.Keywords
This publication has 16 references indexed in Scilit:
- Severe retinopathy of prematurity (ROP) in a premature baby treated with sildenafil acetate (Viagra) for pulmonary hypertensionBritish Journal of Ophthalmology, 2004
- Indian doctor in protest after using Viagra to save “blue babies”BMJ, 2002
- Oral Sildenafil Is an Effective and Specific Pulmonary Vasodilator in Patients With Pulmonary Arterial HypertensionCirculation, 2002
- Intravenous Sildenafil Lowers Pulmonary Vascular Resistance in a Model of Neonatal Pulmonary HypertensionAmerican Journal of Respiratory and Critical Care Medicine, 2002
- Effect of Inhaled Iloprost Plus Oral Sildenafil in Patients With Primary Pulmonary HypertensionCirculation, 2001
- Sildenafil in Primary Pulmonary HypertensionNew England Journal of Medicine, 2000
- Sildenafil as a selective pulmonary vasodilator in childhood primary pulmonary hypertensionHeart, 2000
- Use of sildenafil (Viagra) in patients with cardiovascular diseaseJACC, 1999
- Oral Sildenafil in the Treatment of Erectile DysfunctionNew England Journal of Medicine, 1998
- Nitric oxide and cGMP cause vasorelaxation by activation of a charybdotoxin-sensitive K channel by cGMP-dependent protein kinase.Proceedings of the National Academy of Sciences, 1994